IAPAC
@IAPAC
30,000+ members working to end AIDS as a public health threat by 2030 and core partner of @FastTrackCities @FTC2030; President: @JoseM_Zuniga
The US @FastTrackCities 2025 Summit will convene elected and public health officials, clinicians, service providers, and community leaders 15-17 September 2025 to discuss the way forward in an evolving #HIV policy environment and dire budget constraints. iapac.org/conferences/us…
Are you a US-based/practicing clinician delivering #HIV and related care/services? A joint Emergency HIV Clinical Services Survey closes at 5 pm ET, July 28th. Take a few minutes to offer your insights: iapac.qualtrics.com/jfe/form/SV_3B…
10 years into its existence, we are still welcoming cities into the @FastTrackCities network. We welcome @CMSeixal joining 550+ cities around the world committed to ending urban #HIV epidemics.
US #FastTrackCities: Have you submitted your abstracts for the US Fast-Track Cities 2025 Summit (15-17 September 2025 in New Orleans)? If not, the deadline is July 30, 2025. Learn more: iapac.org/conferences/us…
The #HIV Medication Access Act is a step towards equity, expanding access to #PrEP through @PEPFAR. But it’s just a proposal for now. We need Congress to act. Lives depend on it. Let’s turn science into access and access into justice. ansari.house.gov/media/press-re…
Today is #ZeroHIVStigmaDay. Access the 2025 campaign’s website for information and tools for #HIVStigmaWarriors. ZeroHIVStigma.org
NEW IN @JIAPAC_AIDS: Moving Beyond Viral Suppression: Poor Patient-Provider Communication and its Impact on Healthcare Outcomes among People Living with #HIV in the United States journals.sagepub.com/doi/10.1177/23…
#HIV prevention is not one-size-fits-all. From oral to injectable #PrEP, patient autonomy must guide what works best for them. When we respect choice we respect people. #HIVPrevention #PersonCenteredCare 💊💉
🌟Just launched at #IAS2025! Check out our new supplement on expanding HIV prevention choice across diverse settings and populations. bit.ly/JIASPrEP
We applaud @ViiVHC for the expansion of its voluntary license with the Medicines Patent Pool. This expansion will allow generics manufacturers to develop, manufacture, and supply CAB-LA for #HIV treatment in 133 countries. viivhealthcare.com/hiv-news-and-m…
#News for #Investors and #Media: We've expanded our voluntary license with the Medicines Patent Pool to include further innovative treatments alongside prevention to enable increased access and reach those most impacted by #HIV. Find out more 👉 viivhealthcare.com
Bottomline on LEN and what we join @UNAIDS in demanding from @GileadSciences: • swiftly register LEN for regulatory approval in all LMICs • ensure affordable (equitable) access to LEN for all We call on @IAPAC’s 30,000 clinician-members to make your voices heard. #Equity
UNAIDS welcomes new @WHO guidelines on Lenacapavir and urges @GileadSciences to swiftly register it for regulatory approval in all low- & middle-income countries, starting with those with highest HIV incidence, and ensure affordable access for all. Press statement ⤵️
Register today for the 2025 #ZeroHIVStigmaDay Uniting #HIVStigmaWarriors webinar taking place July 21st. The webinar will feature the release and discussion about the new report, ‘Unmasking Stigma, Mobilizing Resilience’ report. REGISTER: zoom.us/webinar/regist…
Our new #HIV policy brief calls for a bold reimagining of US #HIV prevention ecosystem centered on equity and fully community-anchored. @GileadSciences’ lenacapavir for #PrEP is a tool and a test. Will we deliver for all? iapac.org/2025/07/03/hiv…
ALERT: The @WHO released guidance today on long-acting #lenacapavir for #HIV PrEP. #IAS2025 @aahivmcomm @HIVMA @EACSociety @SAHIVSoc READ: who.int/publications/i…
We proudly signed on to an @AFTunion ad published in the @nytimenews today, joining 140+ organizations in declaring a betrayal of American values in the #BigUglyBill and its cruel budget that guts healthcare. aft.org/they-betrayed-…
ALERT: @UNAIDS reports 29.6 million lives saved thanks to #HIV treatment. We were on an upward trajectory towards ending #AIDS-related deaths, jeopardized by reckless Trump administration decisions. The time for timid pleading is over. Time to act! unaids.org/en/UNAIDS-glob…
A noble gesture like no-profit pricing is something we can all celebrate. Confused why then @GileadSciences required the @GlobalFund to observe price secrecy? Seeking clarity.
#GileadNews: Today, we announced an agreement with @GlobalFund to supply our long-acting #HIV prevention medication for up to two million people over three years in low- and lower-middle-income countries upon approval, at no profit to us. gilead.inc/44R1fsR
We agree with @HealthGAP that @GileadSciences and the @GlobalFund should disclose price at which LAI #lenacapavir for #PrEP is being procured. Accountability must extend to the % Gilead Sciences will commit to invest in implementation. healthgap.org/press/gilead-i…
Welcome @AIDSUnited as a Summit partner. We encourage US @FastTrackCities to submit abstracts and register online today: iapac.org/conferences/us…
Welcome @NMACCommunity @NACCHOalerts & @NASTAD as our @FastTrackCities Summit partners. Join us September 15-17, 2025, as we plot a path forward for US urban #HIV responses. iapac.org/conferences/us…
We stand in opposition to the so-called “Big Beautiful Bill” to be codified today. Its impact on #Medicaid alone is cruel with its denial of healthcare coverage to millions of medically indigent Americans, including people living with #HIV.
US Senate passed ‘One Big Beautiful Bill’ but there is zero beautiful about SLASHING #Medicaid access for millions. 💊 Fewer #HIV services 🏥 Gutting health access in all 50 states (no exceptions) 📢 Tell US House to REJECT this attack on health.
Welcome @NMACCommunity @NACCHOalerts & @NASTAD as our @FastTrackCities Summit partners. Join us September 15-17, 2025, as we plot a path forward for US urban #HIV responses. iapac.org/conferences/us…
